Q2 2014 13F Holders as of 6/30/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
236M
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
6.58M
-
Shares change
-
+6.48M
-
Total reported value, excl. options
-
$183M
-
Value change
-
+$181M
-
Number of buys
-
47
-
Number of sells
-
-3
-
Price
-
$27.79
Significant Holders of Akebia Therapeutics, Inc. - Common Stock (AKBA) as of Q2 2014
51 filings reported holding AKBA - Akebia Therapeutics, Inc. - Common Stock as of Q2 2014.
Akebia Therapeutics, Inc. - Common Stock (AKBA) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.58M shares
of 236M outstanding shares and own 2.79% of the company stock.
Largest 10 shareholders include Novo A/S (1.52M shares), FMR LLC (1.02M shares), HealthCor Management, L.P. (900K shares), FRANKLIN RESOURCES INC (510K shares), STIFEL FINANCIAL CORP (445K shares), Cormorant Asset Management, LLC (400K shares), MORGAN STANLEY (397K shares), BlackRock Fund Advisors (193K shares), JENNISON ASSOCIATES LLC (179K shares), and EVENTIDE ASSET MANAGEMENT, LLC (166K shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.